EVIO Labs Florida (Broward County, Florida) was recently recognized for their participation in The Emerald Test (Emerald Scientific), which is an interlaboratory comparison and proficiency assessment for cannabis testing. According to the company’s press release, EVIO Florida was recognized by Emerald for their accuracy in potency in solution, residual solvents, terpenes, microbial 2, aspergillus mold, pesticide screening, and mycotoxin testing.
“Our experienced team of chemists are among the best in the industry and these awards provide the acknowledgement of our efforts to operate above the standard,” said Chris Martinez, President EVIO Florida, in the press release.
The Emerald Test reportedly uses the standard interlaboratory comparison proficiency testing (ILC/PT) program for evaluating how accurately and dependably testing laboratories perform, by comparing how well the laboratory measures blinded samples. ILC/PT programs are common in many testing industries (such as environmental, food, pharmaceutical, and more), and provide a point of reference on how well testing laboratories perform individually and collectively.
According to the company, the Emerald Test acknowledgement helps demonstrate EVIO Florida’s aptitude and competence in conducting analytical testing at a higher standard of excellence for Florida’s cannabis industry. In addition, the Emerald Test badge results provide a measure of assurance and reliability to those who depend on precise laboratory results for patient safety, public health, and product precision.
For more information, contact info@eviolabsfl.com.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.